Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.22 USD | +1.67% | +4.92% | -11.18% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 26.39 | 29.61 | 28.61 |
Spread/Res. | -0.64% | -11.45% | -8.35% |
Spread/Supp. | +11.24% | +11.24% | +10.12% |
Support | 23.57 | 23.57 | 23.81 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MIRM Stock
- Charts Mirum Pharmaceuticals, Inc.